https://ir.castlebiosciences.com/ https://ir.castlebiosciences.com/news-events/press-releases https://ir.castlebiosciences.com/news-events/ir-events https://ir.castlebiosciences.com/news-events/presentations https://ir.castlebiosciences.com/news-events/in-the-media https://ir.castlebiosciences.com/news-events/annual-meeting https://ir.castlebiosciences.com/news-events/email-alerts https://ir.castlebiosciences.com/company-info https://ir.castlebiosciences.com/company-info/annual-reports-proxy https://ir.castlebiosciences.com/company-info/contacts https://ir.castlebiosciences.com/company-info/faq https://ir.castlebiosciences.com/financial-info/financial-results https://ir.castlebiosciences.com/financial-info/income-statement https://ir.castlebiosciences.com/financial-info/balance-sheet https://ir.castlebiosciences.com/financial-info/cash-flow https://ir.castlebiosciences.com/stock-data/quote-chart https://ir.castlebiosciences.com/stock-data/historical-data https://ir.castlebiosciences.com/stock-data/analyst-coverage https://ir.castlebiosciences.com/sec-filings/all-sec-filings https://ir.castlebiosciences.com/sec-filings/annual-reports https://ir.castlebiosciences.com/sec-filings/quarterly-reports https://ir.castlebiosciences.com/sec-filings/section-16-filings https://ir.castlebiosciences.com/governance https://ir.castlebiosciences.com/governance/board-committees https://ir.castlebiosciences.com/governance/governance-documents https://ir.castlebiosciences.com/news-events/press-releases/detail/469/castle-biosciences-to-present-at-the-2026-jefferies-global-healthcare-conference 2026-05-13T07:00:11-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/468/castle-biosciences-advancead-tx-test-receives-2026-medtech-breakthrough-award-for-genomics-innovation 2026-05-12T07:00:21-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/467/castle-biosciences-reports-first-quarter-2026-results 2026-05-06T16:05:16-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/466/castle-biosciences-supports-nationwide-patient-advocacy-and-screening-initiatives-to-celebrate-skin-cancer-awareness-month 2026-05-05T07:00:22-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/465/new-data-at-ddw-2026-show-tissuecypher-testing-improves-risk-stratification-and-drives-risk-aligned-management-in-barretts-esophagus 2026-05-04T07:27:21-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/464/castle-biosciences-to-present-new-data-demonstrating-decisiondx-melanomas-ability-to-identify-patients-with-greater-risk-of-recurrence-and-poor-outcomes-within-early-stage-melanoma-at-eado-and-acms 2026-04-22T10:59:32-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/463/castle-biosciences-to-release-first-quarter-2026-financial-results-and-host-webcast-on-wednesday-may-6-2026 2026-04-15T07:00:05-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/462/castle-biosciences-earns-2026-usa-today-top-workplaces-award-for-fifth-consecutive-year 2026-04-10T07:00:03-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/461/castle-biosciences-decisiondx-melanoma-test-significantly-improves-risk-prediction-within-ajcc-stages-to-support-personalized-risk-aligned-management-of-cutaneous-melanoma-data-to-be-presented-at-aad-2026 2026-03-27T09:05:02-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/85/prospective-multi-center-study-published-in-future-oncology-demonstrates-decisiondx-melanomas-i31-slnb-result-outperforms-staging-criteria-in-identifying-patients-with-cutaneous-melanoma-below-the-5-nccn-threshold-for-forgoing-slnb 2026-03-23T10:44:50-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/86/decisiondx-melanomas-i31-slnb-report-from-the-largest-prospective-multicenter-study-to-date-confirms-2-6-nodal-positivity-in-patients-predicted-to-have-less-than-5-risk 2026-03-23T10:44:50-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/87/castle-biosciences-to-present-data-at-sso-2026-on-decisiondx-melanomas-i31-slnb-identifying-t1bt2a-melanoma-patients-who-may-safely-avoid-slnb 2026-03-23T10:44:50-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/88/castle-biosciences-announces-grand-opening-of-new-corporate-headquarters-in-friendswood-texas 2026-03-23T10:44:50-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/89/castle-biosciences-reports-fourth-quarter-and-fullyear-2025-results 2026-03-23T10:44:50-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/90/prospective-validation-study-in-jaad-demonstrates-castle-biosciences-advancead-tx-test-identifies-patients-more-likely-to-achieve-faster-and-deeper-responses-with-jak-inhibitor-therapy-in-moderate-to-severe-atopic-dermatitis 2026-03-23T10:44:51-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/91/castle-biosciences-to-release-fourth-quarter-and-full-year-2025-financial-results-and-host-conference-call-on-thursday-feb-26-2026 2026-03-23T10:44:51-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/92/castle-biosciences-announces-preliminary-unaudited-fourth-quarter-and-fullyear-2025-results 2026-05-20T09:36:26-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/93/castle-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635c4 2026-03-23T10:44:51-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/94/landmark-study-shows-combination-of-castle-biosciences-decisiondx-um-and-prame-outperforms-gene-mutation-analysis-in-predicting-survival-outcomes-in-uveal-melanoma 2026-03-23T10:44:51-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/95/systematic-review-and-meta-analysis-confirms-tissuecypher-outperforms-traditional-pathology-or-clinical-factors-alone-to-identify-patients-at-increased-risk-of-developing-esophageal-cancer 2026-03-23T10:44:51-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/96/expert-melanoma-panel-recommends-castle-biosciences-decisiondx-melanoma-as-a-best-practice-tool-for-managing-patients-with-melanoma 2026-03-23T10:44:51-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/97/castle-biosciences-earns-a-houston-chronicle-top-workplaces-award-for-the-fifth-consecutive-year 2026-03-23T10:44:51-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/98/new-data-confirms-performance-of-decisiondx-melanoma-to-identify-patients-with-less-than-five-percent-risk-of-sentinel-lymph-node-positivity 2026-03-23T10:44:51-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/99/castle-biosciences-to-present-at-the-piper-sandler-37th-annual-healthcare-conference 2026-03-23T10:44:51-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/100/castle-biosciences-reports-third-quarter-2025-results 2026-03-23T10:44:52-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/101/castle-biosciences-launches-advancead-tx-to-help-guide-systemic-treatment-decision-making-in-patients-with-moderate-to-severe-atopic-dermatitis 2026-03-23T10:44:52-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/102/castle-biosciences-to-participate-in-upcoming-investor-conferences 2026-03-23T10:44:52-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/103/new-data-at-american-college-of-gastroenterology-annual-meeting-show-tissuecypher-provides-actionable-risk-insights-that-influence-clinical-management-and-prompt-risk-aligned-intervention-in-barretts-esophagus 2026-03-23T10:44:52-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/104/new-analysis-of-13560-patients-demonstrates-decisiondx-melanoma-stratifies-risk-across-histological-subtypes-findings-to-be-presented-at-fall-clinical-dermatology-conference 2026-03-23T10:44:52-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/105/castle-biosciences-to-release-third-quarter-2025-financial-results-and-host-conference-call-on-monday-nov-3-2025 2026-03-23T10:44:52-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/106/castle-biosciences-founder-president-and-ceo-derek-maetzold-honored-with-the-ceo-of-the-year-award-by-the-ceo-magazine 2026-03-23T10:44:52-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/107/castle-biosciences-honored-with-a-greater-pittsburgh-top-workplaces-2025-award 2026-03-23T10:44:52-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/108/castle-biosciences-named-one-of-newsweeks-americas-greatest-companies-2025 2026-03-23T10:44:52-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/109/new-data-at-american-foregut-societys-2025-annual-meeting-demonstrates-tissuecypher-can-detect-high-risk-barretts-esophagus-patients-not-identified-by-pathology-to-support-improved-care-decisions 2026-03-23T10:44:53-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/110/new-evidence-published-supporting-use-of-decisiondx-scc-test-in-guiding-and-improving-treatment-pathway-decisions-in-nccn-high-risk-cutaneous-squamous-cell-carcinoma 2026-03-23T10:44:53-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/111/castle-biosciences-to-participate-in-upcoming-investor-conferences 2026-03-23T10:44:53-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/112/castle-biosciences-reports-second-quarter-2025-results 2026-03-23T10:44:54-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/113/castle-biosciences-to-present-at-the-canaccord-genuity-45th-annual-growth-conference 2026-03-23T10:44:54-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/114/castle-biosciences-founder-president-and-ceo-derek-maetzold-named-a-most-admired-ceo-by-the-houston-business-journal 2026-03-23T10:44:54-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/115/fda-grants-breakthrough-device-designation-to-castle-biosciences-decisiondx-melanoma-test 2026-03-23T10:44:54-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/116/castle-biosciences-honored-with-multiple-top-workplaces-awards-recognizing-the-companys-strong-culture 2026-03-23T10:44:54-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/117/castle-biosciences-to-release-second-quarter-2025-financial-results-and-host-conference-call-on-monday-aug-4-2025 2026-03-23T10:44:54-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/118/castle-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635c4 2026-03-23T10:44:55-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/119/castle-biosciences-enters-collaboration-and-license-agreement-with-scibase-to-develop-diagnostic-tests-for-dermatologic-diseases 2026-03-23T10:44:56-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/120/castle-biosciences-chief-executive-officer-derek-maetzold-to-participate-in-panel-discussion-during-the-2025-bio-international-convention 2026-03-23T10:44:56-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/121/castle-biosciences-founder-president-and-ceo-derek-maetzold-honored-with-prestigious-lifetime-achievement-award-by-the-american-business-awards 2026-03-23T10:44:56-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/122/new-data-at-asco-2025-affirms-decisiondx-melanomas-ability-to-improve-upon-staging-based-risk-stratification-and-predict-survival-outcomes 2026-03-23T10:44:56-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/123/castle-biosciences-to-present-at-the-2025-jefferies-global-healthcare-conference 2026-03-23T10:44:56-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/124/real-world-study-confirms-long-term-performance-of-decisiondx-um-for-metastatic-risk-stratification-in-uveal-melanoma-and-utility-of-prame-biomarker-for-refining-risk-when-considered-with-the-decisiondx-um-class-result 2026-03-23T10:44:56-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/125/castle-biosciences-celebrates-skin-cancer-awareness-month 2026-03-23T10:44:56-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/126/castle-biosciences-reports-first-quarter-2025-results 2026-03-23T10:44:56-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/127/castle-biosciences-to-acquire-previse 2026-03-23T10:44:56-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/128/new-data-at-ddw-2025-further-demonstrates-the-tissuecypher-tests-ability-to-identify-patients-at-increased-risk-for-developing-esophageal-cancer 2026-03-23T10:44:56-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/129/new-study-shows-castle-biosciences-decisiondx-melanoma-test-outperforms-staging-and-cp-gep-in-identifying-patients-at-low-risk-of-sentinel-lymph-node-positivity 2026-03-23T10:44:57-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/130/decisiondx-melanoma-test-ordered-more-than-200000-times-for-patients-diagnosed-with-cutaneous-melanoma 2026-03-23T10:44:57-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/131/new-data-at-aacr-annual-meeting-highlights-use-of-decisiondx-melanoma-to-identify-early-stage-melanoma-patients-at-high-risk-of-distant-metastasis 2026-03-23T10:44:57-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/132/castle-biosciences-to-release-first-quarter-2025-financial-results-and-host-conference-call-on-monday-may-5-2025 2026-03-23T10:44:57-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/133/castle-biosciences-strengthens-commitment-to-esophageal-cancer-awareness-through-collaborative-partnerships 2026-03-23T10:44:57-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/134/castle-biosciences-honored-with-a-top-workplaces-usa-award-for-fourth-consecutive-year 2026-03-23T10:44:57-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/135/publication-of-data-from-prospective-multicenter-study-demonstrates-positive-survival-outcomes-in-patients-with-low-risk-melanoma-who-avoided-sentinel-lymph-node-biopsy-with-information-from-castle-biosciences-decisiondx-melanoma-test 2026-03-23T10:44:57-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/136/castle-biosciences-to-present-new-data-at-eado-supporting-the-clinical-value-of-the-decisiondx-melanoma-test-in-guiding-risk-aligned-management-of-patients-with-melanoma 2026-03-23T10:44:57-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/137/castle-biosciences-decisiondx-scc-data-earns-top-five-abstract-at-nccn-2025-shows-significantly-enhanced-risk-stratification-beyond-current-staging-within-nccn-risk-groups 2026-03-23T10:44:57-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/138/new-data-to-be-presented-at-the-2025-american-academy-of-dermatology-aad-annual-meeting-further-strengthens-evidence-supporting-the-clinical-value-of-castle-biosciences-dermatology-portfolio 2026-03-23T10:44:57-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/139/castle-biosciences-reports-fourth-quarter-and-full-year-2024-results 2026-03-23T10:44:57-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/140/castle-biosciences-to-participate-in-upcoming-investor-conferences 2026-03-23T10:44:58-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/141/castle-biosciences-to-share-data-reinforcing-the-clinical-value-of-its-dermatologic-portfolio-of-gene-expression-profile-tests-at-the-22nd-annual-winter-clinical-dermatology-conference---hawaii 2026-03-23T10:44:58-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/142/castle-biosciences-to-release-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-thursday-feb-27-2025 2026-03-23T10:44:58-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/143/castles-poster-on-decisiondx-scc-selected-as-a-late-breakers-top-five-finalist-for-the-akamai-award-recognizing-the-best-posters-at-maui-derm-hawaii-2025 2026-03-23T10:44:58-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/144/castle-biosciences-announces-preliminary-unaudited-fourth-quarter-and-full-year-2024-results 2026-03-23T10:44:58-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/145/castle-biosciences-announces-new-york-state-department-of-health-approval-of-its-tissuecypher-barretts-esophagus-test 2026-03-23T10:44:58-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/146/castle-biosciences-highlights-progress-for-its-pipeline-atopic-dermatitis-gene-expression-profile-test 2026-03-23T10:44:58-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/147/castle-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635c4 2026-03-23T10:44:58-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/148/independent-systematic-review-and-meta-analysis-attests-to-the-significant-risk-stratification-provided-by-castle-biosciences-decisiondx-melanoma-test-contributing-to-personalized-management-of-patients-with-melanoma 2026-03-23T10:44:58-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/149/castle-biosciences-to-present-at-the-piper-sandler-36th-annual-healthcare-conference 2026-03-23T10:44:59-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/150/castle-biosciences-earns-a-houston-chronicle-top-workplaces-award-for-the-fourth-consecutive-year 2026-03-23T10:44:59-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/151/castle-biosciences-to-present-new-data-highlighting-the-clinical-performance-of-decisiondx-melanoma-and-mypath-melanoma-at-the-american-society-of-dermatopathology-61st-annual-meeting 2026-03-23T10:44:59-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/152/castle-biosciences-surpasses-25000-test-reports-delivered-for-its-tissuecypher-barretts-esophagus-test 2026-03-23T10:44:59-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/153/use-of-castle-biosciences-decisiondx-melanoma-test-significantly-reduces-unnecessary-slnb-procedures-latest-findings-from-prospective-multicenter-decide-study-presented-at-dermato-onco2024 2026-03-23T10:44:59-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/154/castle-biosciences-reports-third-quarter-2024-results 2026-03-23T10:44:59-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/155/castle-biosciences-presents-award-winning-abstract-at-acg-2024-demonstrating-ability-of-its-tissuecypher-test-to-significantly-reduce-healthcare-costs-associated-with-the-management-of-barretts-esophagus-patients 2026-03-23T10:44:59-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/156/castle-biosciences-to-participate-in-upcoming-investor-conferences 2026-03-23T10:44:59-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/157/castle-biosciences-presents-new-data-at-asds-from-prospective-multicenter-connection-study-supporting-use-of-decisiondx-melanoma-to-guide-slnb-decisions-in-t1a-tumors-with-high-risk-features-and-t1b-tumors 2026-03-23T10:44:59-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/158/recent-publications-affirm-the-value-of-gene-expression-profile-testing-in-guiding-a-definitive-diagnosis-and-clinical-decision-making-in-melanocytic-lesions-of-uncertain-malignant-potential 2026-03-23T10:45:00-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/159/castle-biosciences-to-release-third-quarter-2024-financial-results-and-host-conference-call-on-monday-nov-4-2024 2026-03-23T10:45:00-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/160/castle-biosciences-to-support-the-71st-annual-montagna-symposium-on-the-biology-of-the-skin 2026-03-23T10:45:00-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/161/new-prospective-multicenter-study-presented-at-smr-demonstrates-castle-biosciences-decisiondx-melanoma-test-provides-significant-risk-prediction-for-patients-with-cutaneous-melanoma-adding-value-to-current-stage-based-treatment-pathway-decisions 2026-03-23T10:45:00-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/162/castle-biosciences-hosts-groundbreaking-ceremony-at-site-of-new-corporate-headquarters-in-friendswood-texas 2026-03-23T10:45:00-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/163/new-data-at-astro-2024-shows-castle-biosciences-decisiondx-scc-test-provides-more-precise-risk-stratification-than-bwh-staging-alone-to-guide-intensified-treatment-for-immune-suppressed-patients-with-high-risk-cutaneous-squamous-cell-carcinoma 2026-03-23T10:45:00-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/164/new-data-at-afs-2024-demonstrates-the-strength-of-castle-biosciences-tissuecypher-test-in-independently-predicting-risk-of-developing-esophageal-cancer-guiding-risk-aligned-management-decisions-for-patients-with-barretts-esophagus 2026-03-23T10:45:00-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/165/castle-biosciences-chief-operating-officer-kristen-oelschlager-named-arizona-bioscience-leader-of-the-year 2026-03-23T10:45:00-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/166/decisiondx-melanoma-can-identify-melanoma-patients-with-low-risk-of-sentinel-lymph-node-positivity-who-may-safely-forego-biopsy-surgery-new-independent-study-affirms 2026-03-23T10:45:00-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/167/study-confirms-the-ability-of-castle-biosciences-decisiondx-scc-test-to-predict-likelihood-of-benefit-from-adjuvant-radiation-therapy-in-patients-with-high-risk-cutaneous-squamous-cell-carcinoma 2026-03-23T10:45:00-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/168/castle-biosciences-to-participate-in-upcoming-investor-conferences 2026-03-23T10:45:01-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/169/castle-biosciences-reports-second-quarter-2024-results 2026-03-23T10:45:01-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/170/castle-biosciences-to-present-at-the-canaccord-genuity-44th-annual-growth-conference 2026-03-23T10:45:01-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/171/castle-biosciences-and-skin-cancer-survivor-teddi-mellencamp-arroyave-launch-campaign-to-increase-awareness-of-melanoma 2026-03-23T10:45:01-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/172/castle-biosciences-to-release-second-quarter-2024-financial-results-and-host-conference-call-on-monday-aug-5-2024 2026-03-23T10:45:01-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/173/castle-biosciences-honored-with-top-workplaces-awards 2026-03-23T10:45:01-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/174/recent-aga-clinical-practice-guideline-acknowledges-that-individuals-who-may-be-at-increased-risk-of-progression-to-esophageal-cancer-might-be-identified-using-tissue-based-biomarkers-particularly-castle-biosciences-tissuecypher-test 2026-03-23T10:45:02-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/175/castle-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635c4 2026-03-23T10:45:02-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/176/castle-biosciences-founder-president-and-ceo-derek-maetzold-named-an-ey-entrepreneur-of-the-year-2024-gulf-south-award-winner 2026-03-23T10:45:02-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/177/castle-biosciences-to-present-new-data-at-2024-asco-annual-meeting-highlighting-use-of-decisiondx-melanoma-to-identify-early-stage-melanoma-patients-at-high-risk-of-metastasis-to-the-central-nervous-system-to-prompt-use-of-imaging-surveillance 2026-03-23T10:45:02-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/178/new-publication-shows-decisiondx-scc-identifies-high-risk-squamous-cell-carcinoma-patients-who-are-likely-to-benefit-from-adjuvant-radiation-therapy-and-those-who-can-consider-deferring-treatment-based-on-biological-risk-of-metastasis 2026-03-23T10:45:02-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/179/castle-biosciences-to-present-at-the-leerink-partners-healthcare-crossroads-conference 2026-03-23T10:45:02-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/180/castle-biosciences-expands-evidence-supporting-the-performance-of-its-tissuecypher-barretts-esophagus-test-in-predicting-future-development-of-esophageal-cancer-through-multiple-data-presentations-at-ddw-2024 2026-03-23T10:45:02-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/181/castle-biosciences-idgenetix-test-receives-2024-medtech-breakthrough-award-for-best-overall-mental-health-solution 2026-03-23T10:45:02-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/182/largest-prospective-study-to-date-further-supports-performance-of-decisiondx-um-for-metastatic-risk-stratification-in-uveal-melanoma-and-utility-of-prame-biomarker-for-refining-risk-when-considered-with-decisiondx-um-class-result 2026-03-23T10:45:02-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/183/decisiondx-scc-significantly-improves-prediction-accuracy-of-metastatic-events-after-mohs-surgery-in-new-study-of-patients-with-high-risk-cutaneous-squamous-cell-carcinoma-tumors-of-the-head-and-neck 2026-03-23T10:45:02-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/184/castle-biosciences-reports-first-quarter-2024-results 2026-03-23T10:45:03-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/185/castle-biosciences-kicks-off-skin-cancer-awareness-month-with-a-ribbon-cutting-to-celebrate-the-city-of-friendswoods-designation-as-a-sun-safe-leadership-model-city-by-impact-melanoma 2026-03-23T10:45:03-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/186/castle-biosciences-to-release-first-quarter-2024-financial-results-and-host-conference-call-on-thursday-may-2-2024 2026-03-23T10:45:03-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/187/castle-biosciences-celebrates-esophageal-cancer-awareness-month-through-advocacy-and-educational-collaborations 2026-03-23T10:45:03-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/188/castle-biosciences-chief-financial-officer-frank-stokes-recognized-as-a-top-cfo-of-houston-for-second-consecutive-year 2026-03-23T10:45:03-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/189/presentations-at-eado-highlight-potential-impact-of-castle-biosciences-decisiondx-melanoma-and-decisiondx-scc-tests-on-the-management-of-patients-with-skin-cancer 2026-03-23T10:45:03-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/190/castle-biosciences-to-present-at-the-23rd-annual-needham-virtual-healthcare-conference 2026-03-23T10:45:03-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/191/castle-biosciences-announces-updates-to-its-board-of-directors 2026-03-23T10:45:03-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/192/castle-biosciences-earns-a-top-workplaces-usa-award-for-the-third-consecutive-year 2026-03-23T10:45:03-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/193/long-term-outcomes-data-shared-at-sso-2024-show-that-patients-with-a-low-risk-decisiondx-melanoma-test-result-were-recurrence-free-at-three-years-including-those-who-utilized-the-test-to-help-guide-the-decision-to-avoid-an-slnb 2026-03-23T10:45:04-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/194/leading-squamous-cell-carcinoma-practitioners-publish-consensus-guidelines-integrating-decisiondx-scc-into-a-clinical-workflow-to-improve-decision-making-regarding-the-use-of-adjuvant-radiation-therapy 2026-03-23T10:45:04-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/195/new-study-shows-that-the-drug-drug-interactions-and-lifestyle-factors-provided-by-castle-biosciences-idgenetix-test-significantly-improve-medication-recommendations-over-drug-gene-interactions-alone-for-patients-65-and-older 2026-03-23T10:45:04-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/196/castle-biosciences-to-present-at-the-keybanc-capital-markets-virtual-life-sciences-medtech-investor-forum 2026-03-23T10:45:04-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/197/castle-biosciences-to-present-new-data-highlighting-the-clinical-value-of-its-dermatologic-tests-for-patients-with-skin-cancer-at-the-2024-american-academy-of-dermatology-aad-annual-meeting 2026-03-23T10:45:04-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/198/in-novel-cohort-new-data-confirms-decisiondx-scc-provides-significant-independent-and-clinically-actionable-risk-stratification-of-patients-including-in-various-high-risk-subgroups 2026-03-23T10:45:04-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/199/castle-biosciences-reports-fourth-quarter-and-full-year-2023-results 2026-03-23T10:45:05-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/200/study-finds-decisiondx-melanoma-significantly-improves-the-risk-stratification-of-patients-with-stage-i-melanoma-compared-to-american-joint-committee-on-cancer-8th-edition-staging 2026-03-23T10:45:05-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/201/castle-biosciences-to-release-fourth-quarter-and-full-year-2023-financial-results-and-host-conference-call-on-wednesday-feb-28-2024 2026-03-23T10:45:05-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/202/new-study-highlights-significant-potential-medicare-savings-through-use-of-castle-biosciences-decisiondx-scc-test-to-guide-adjuvant-radiation-therapy-decisions-in-patients-with-cutaneous-squamous-cell-carcinoma 2026-03-23T10:45:05-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/203/castle-biosciences-presents-data-supporting-the-utility-of-its-tests-in-the-clinical-care-of-patients-with-skin-cancers-at-the-2024-winter-clinical-dermatology-conference---hawaii 2026-03-23T10:45:05-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/204/castle-biosciences-chief-operating-officer-kristen-oelschlager-selected-among-the-top-25-women-leaders-in-biotechnology-by-the-healthcare-technology-report 2026-03-23T10:45:05-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/205/castle-biosciences-announces-preliminary-fourth-quarter-and-full-year-2023-results 2026-03-23T10:45:05-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/206/castle-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635c4 2026-03-23T10:45:05-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/207/study-finds-nurse-practitioners-and-physician-assistants-would-alter-patient-care-decisions-based-on-decisiondx-melanoma-test-results 2026-03-23T10:45:05-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/208/castle-biosciences-announces-multiple-data-presentations-at-the-2023-american-society-for-dermatologic-surgery-annual-meeting 2026-03-23T10:45:06-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/209/castle-biosciences-ranked-among-the-top-workplaces-in-houston-by-the-houston-chronicle-for-the-third-consecutive-year 2026-03-23T10:45:06-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/210/real-world-evidence-confirms-idgenetix-guided-medication-management-significantly-improves-response-and-remission-rates-in-patients-with-major-depressive-disorder 2026-03-23T10:45:06-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/211/castle-biosciences-to-present-at-upcoming-investor-conferences 2026-03-23T10:45:06-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/212/castle-announces-early-exploratory-study-data-for-potential-development-of-a-complementary-test-to-accompany-decisiondx-um-that-could-aid-in-the-early-detection-of-uveal-melanomas 2026-03-23T10:45:06-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/213/early-discovery-data-shows-ability-of-castle-biosciences-pipeline-program-to-distinguish-between-responders-and-non-responders-to-an-atopic-dermatitis-therapy 2026-03-23T10:45:06-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/214/castle-biosciences-reports-third-quarter-2023-results 2026-03-23T10:45:06-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/215/castle-biosciences-to-present-new-data-on-its-tissuecypher-barretts-esophagus-test-at-the-2023-american-college-of-gastroenterology-annual-scientific-meeting 2026-03-23T10:45:06-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/216/castle-biosciences-to-release-third-quarter-2023-financial-results-and-host-conference-call-on-thursday-nov-2 2026-03-23T10:45:06-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/217/new-data-highlights-clinical-utility-and-performance-of-castle-biosciences-dermatologic-test-portfolio-at-the-2023-fall-clinical-dermatology-conference 2026-03-23T10:45:07-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/218/decisiondx-melanoma-outperforms-memorial-sloan-kettering-cancer-center-mskcc-nomogram-in-predicting-sentinel-lymph-node-positivity-in-patients-with-cutaneous-melanoma 2026-03-23T10:45:07-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/219/castle-biosciences-presents-new-data-at-astro-2023-highlighting-risk-stratification-performance-of-decisiondx-scc-in-patients-with-cutaneous-squamous-cell-carcinoma-eligible-for-adjuvant-radiation-therapy 2026-03-23T10:45:07-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/220/castle-biosciences-shares-new-data-demonstrating-ability-of-tissuecypher-test-results-to-inform-clinical-decision-making-in-patients-with-non-dysplastic-barretts-esophagus 2026-03-23T10:45:07-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/221/castle-biosciences-leading-skin-cancer-expert-darrell-rigel-m-d-m-s-and-impact-melanoma-board-member-to-ring-nasdaq-closing-bell-on-sept-27-2023-to-raise-awareness-of-melanoma 2026-03-23T10:45:07-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/222/castle-biosciences-ranked-third-among-2023-top-workplaces-in-the-healthcare-industry 2026-03-23T10:45:07-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/223/tissuecypher-barretts-esophagus-test-outperformed-standard-of-care-in-risk-stratifying-patients-with-barretts-esophagus 2026-03-23T10:45:07-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/224/castle-biosciences-announces-receipt-of-new-york-laboratory-permit-for-pittsburgh-laboratory 2026-03-23T10:45:07-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/225/integrating-drug-drug-interactions-and-lifestyle-factors-with-drug-gene-interactions-provided-by-castle-biosciences-idgenetix-test-significantly-impacted-the-number-of-drug-recommendations-for-patients-with-moderate-to-severe-depression 2026-03-23T10:45:07-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/226/tissuecypher-provides-clinically-impactful-risk-stratification-in-patients-with-barretts-esophagus 2026-03-23T10:45:08-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/227/castle-biosciences-to-highlight-clinical-value-of-idgenetix-test-at-psych-congress-2023 2026-03-23T10:45:08-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/228/castle-biosciences-to-participate-in-upcoming-investor-conferences 2026-03-23T10:45:08-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/229/new-publication-highlights-the-ability-of-the-tissuecypher-barretts-esophagus-test-to-improve-and-standardize-the-clinical-management-of-low-grade-dysplasia-in-patients-with-barretts-esophagus 2026-03-23T10:45:08-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/230/castle-biosciences-reports-second-quarter-2023-results 2026-03-23T10:45:08-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/231/castle-biosciences-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference 2026-03-23T10:45:08-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/232/castle-biosciences-to-release-second-quarter-2023-financial-results-and-host-conference-call-on-wednesday-aug-2 2026-03-23T10:45:08-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/233/castle-biosciences-to-host-second-annual-castle-cares-charity-walk 2026-03-23T10:45:09-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/234/castle-biosciences-honored-as-an-arizona-top-workplace-for-the-second-consecutive-year 2026-03-23T10:45:09-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/235/castle-biosciences-to-present-new-decisiondx-scc-and-decisiondx-melanoma-data-at-the-american-head-neck-societys-ahns-11th-international-conference-on-head-and-neck-cancer 2026-03-23T10:45:09-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/236/study-data-from-castle-biosciences-collaboration-with-the-national-cancer-institutes-seer-program-registries-published-in-jco-precision-oncology 2026-03-23T10:45:09-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/237/castle-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635c4 2026-03-23T10:45:09-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/238/castle-biosciences-presents-new-data-demonstrating-the-ability-of-decisiondx-scc-to-identify-tumors-likely-to-metastasize-in-patients-with-cutaneous-squamous-cell-carcinoma-deemed-low-risk-by-traditional-staging 2026-03-23T10:45:10-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/239/framework-incorporating-decisiondx-scc-test-results-into-clinical-decision-making-for-patients-with-high-risk-cutaneous-squamous-cell-carcinoma-published-in-clinical-cosmetic-and-investigational-dermatology 2026-03-23T10:45:10-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/240/castle-biosciences-to-share-new-data-on-decisiondx-melanoma-and-decisiondx-um-at-the-2023-asco-annual-meeting 2026-03-23T10:45:10-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/241/idgenetix-shown-to-significantly-improve-medication-response-and-remission-rates-in-patients-with-major-depressive-disorder 2026-03-23T10:45:11-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/242/castle-biosciences-celebrates-skin-cancer-awareness-month 2026-03-23T10:45:11-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/243/castle-biosciences-abstracts-at-digestive-disease-week-ddw-annual-meeting-selected-as-posters-of-distinction-by-the-american-gastroenterological-association-aga-institute-council 2026-03-23T10:45:11-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/244/castle-biosciences-opens-new-state-of-the-art-laboratory-in-pittsburgh 2026-03-23T10:45:11-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/245/castle-biosciences-tissuecypher-barretts-esophagus-test-receives-2023-medtech-breakthrough-award-for-artificial-intelligence-innovation 2026-03-23T10:45:11-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/246/castle-biosciences-reports-first-quarter-2023-results 2026-03-23T10:45:11-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/247/study-demonstrates-use-of-decisiondx-melanoma-to-guide-treatment-decisions-resulted-in-earlier-detection-of-melanoma-with-decreased-metastatic-tumor-burden-compared-to-patients-without-surveillance-imaging-studies 2026-03-23T10:45:12-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/248/castle-biosciences-collaborates-with-impact-melanoma-to-provide-free-sunscreen-to-cyclists-participating-in-the-bike-ms-texas-ms-150-2023-cycling-event 2026-03-23T10:45:12-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/249/decisiondx-melanoma-provides-improved-risk-stratification-over-american-joint-committee-on-cancer-ajcc-staging-alone-in-stage-i-melanoma-patients 2026-03-23T10:45:12-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/250/tissuecypher-test-results-can-increase-the-likelihood-of-appropriate-management-decisions-for-barretts-esophagus-patients-with-low-grade-dysplasia 2026-03-23T10:45:12-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/251/castle-biosciences-to-release-first-quarter-2023-financial-results-and-host-conference-call-on-wednesday-may-3 2026-03-23T10:45:12-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/252/castle-biosciences-to-present-at-the-22nd-annual-needham-virtual-healthcare-conference 2026-03-23T10:45:13-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/253/late-breaking-data-presented-at-the-2023-aad-annual-meeting-demonstrates-improved-accuracy-of-decisiondx-scc-in-predicting-metastatic-risk-over-traditional-staging-systems-in-independent-multi-center-cohort-study 2026-03-23T10:45:13-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/254/castle-biosciences-to-present-at-the-keybanc-capital-markets-virtual-life-sciences-medtech-investor-forum 2026-03-23T10:45:13-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/255/castle-biosciences-to-highlight-clinical-value-of-its-skin-cancer-tests-at-the-2023-american-academy-of-dermatology-aad-annual-meeting 2026-03-23T10:45:13-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/256/recommendations-by-expert-consensus-panel-relating-to-risk-stratification-tests-and-tools-for-use-in-cutaneous-melanoma-have-been-adopted-as-an-official-policy-recommendation-of-the-national-society-for-cutaneous-medicine 2026-03-23T10:45:13-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/257/castle-biosciences-reports-fourth-quarter-and-full-year-2022-results 2026-03-23T10:45:13-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/258/castle-biosciences-chief-financial-officer-frank-stokes-selected-among-the-top-25-cfos-of-houston-for-2023-by-finance-investing 2026-03-23T10:45:13-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/259/data-presentation-at-2023-winter-clinical---miami-highlights-use-of-decisiondx-melanoma-to-guide-slnb-surgery-decisions-in-head-and-neck-tumors 2026-03-23T10:45:13-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/260/prospective-multicenter-study-demonstrates-that-decisiondx-melanoma-test-results-can-significantly-reduce-the-number-of-sentinel-lymph-node-biopsy-slnb-procedures-performed-when-used-within-the-context-of-current-guidelines 2026-03-23T10:45:13-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/261/castle-biosciences-to-release-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-on-tuesday-feb-28-2023 2026-03-23T10:45:14-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/262/castle-biosciences-earns-a-top-workplaces-usa-award-for-the-second-consecutive-year 2026-03-23T10:45:14-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/263/castle-biosciences-medical-director-to-present-at-the-precision-medicine-world-conference-2023 2026-03-23T10:45:14-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/264/data-presentations-at-2023-winter-clinical-dermatology-conference---hawaii-support-clinical-value-of-castle-biosciences-skin-cancer-test-portfolio 2026-03-23T10:45:14-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/265/castle-biosciences-announces-preliminary-fourth-quarter-and-full-year-2022-results 2026-03-23T10:45:14-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/266/castle-biosciences-receives-accreditation-from-the-college-of-american-pathologists-for-its-pittsburgh-clinical-laboratory 2026-03-23T10:45:14-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/267/research-published-in-melanoma-management-finds-that-99-of-patients-with-uveal-melanoma-tested-with-decisiondx-um-gain-value-from-the-results 2026-03-23T10:45:14-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/268/castle-biosciences-presents-new-data-demonstrating-the-clinical-utility-and-value-of-decisiondx-scc-in-moderately-and-poorly-differentiated-cutaneous-squamous-cell-carcinoma-tumors 2026-03-23T10:45:14-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/269/castle-biosciences-named-a-houston-chronicle-top-workplace-for-the-second-consecutive-year 2026-03-23T10:45:14-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/270/castle-biosciences-announces-third-quarter-2022-results 2026-03-23T10:45:14-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/271/castle-biosciences-to-present-at-upcoming-investor-conferences 2026-03-23T10:45:15-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/272/real-world-clinical-utility-study-published-in-cancer-investigation-demonstrates-the-impact-of-decisiondx-scc-test-results-in-guiding-risk-aligned-care-for-patients-with-cutaneous-squamous-cell-carcinoma 2026-03-23T10:45:15-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/273/castle-biosciences-presents-new-data-from-collaboration-with-the-national-cancer-institutes-nci-surveillance-epidemiology-and-end-results-seer-program 2026-03-23T10:45:15-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/274/new-data-demonstrate-that-the-utilization-of-tissuecypher-barretts-esophagus-test-results-can-significantly-improve-the-management-of-low-grade-dysplasia-in-patients-with-barretts-esophagus-over-the-standard-of-care-alone 2026-03-23T10:45:15-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/275/castle-biosciences-presents-new-data-demonstrating-the-impact-of-decisiondx-scc-test-results-on-the-management-of-medicare-eligible-patients-with-cutaneous-squamous-cell-carcinoma-and-one-or-more-risk-factors 2026-03-23T10:45:15-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/276/new-data-from-decide-study-show-the-significant-role-of-decisiondx-melanoma-test-results-and-patient-preference-in-decisions-to-perform-the-sentinel-lymph-node-biopsy-slnb-surgical-procedure 2026-03-23T10:45:15-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/277/castle-biosciences-to-release-third-quarter-2022-financial-results-and-host-conference-call-on-wednesday-nov-2 2026-03-23T10:45:15-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/278/results-from-a-randomized-controlled-trial-show-that-tissuecypher-barretts-esophagus-test-results-can-significantly-improve-the-accuracy-of-risk-assessments-and-adherence-to-guideline-recommended-patient-management 2026-03-23T10:45:15-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/279/castle-biosciences-presents-case-study-showcasing-the-diagnostic-performance-of-diffdx-melanoma-at-the-college-of-american-pathologists-2022-cap22-annual-meeting 2026-03-23T10:45:15-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/280/castle-biosciences-to-present-data-supporting-the-clinical-value-of-its-suite-of-skin-cancer-tests-through-multiple-oral-presentations-at-the-2022-american-society-for-dermatologic-surgery-asds-annual-meeting 2026-03-23T10:45:15-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/281/castle-biosciences-announces-publication-of-study-demonstrating-the-integration-of-decisiondx-melanoma-and-clinicopathologic-factors-provides-optimized-personalized-survival-prognoses-for-patients-with-cutaneous-melanoma 2026-03-23T10:45:15-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/282/castle-biosciences-presents-clinical-use-scenarios-for-its-diagnostic-gene-expression-profile-tests-at-maui-derm-np-pa-fall-2022-conference 2026-03-23T10:45:15-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/283/castle-biosciences-presents-foundational-guideposts-and-three-year-financial-targets-at-2022-investor-day 2026-03-23T10:45:15-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/284/castle-biosciences-honored-with-a-2022-azbio-fast-lane-award-from-the-arizona-bioindustry-association 2026-03-23T10:45:16-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/285/castle-biosciences-to-participate-in-upcoming-investor-conferences 2026-03-23T10:45:16-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/286/castle-biosciences-to-host-investor-day-on-sept-20-2022 2026-03-23T10:45:16-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/287/castle-biosciences-reports-second-quarter-2022-results 2026-03-23T10:45:16-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/288/american-gastroenterological-association-aga-clinical-practice-update-states-that-tissuecypher-may-be-beneficial-for-risk-stratification-of-patients-with-non-dysplastic-barretts-esophagus 2026-03-23T10:45:16-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/289/castle-biosciences-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference 2026-03-23T10:45:16-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/290/castle-biosciences-to-release-second-quarter-2022-financial-results-and-host-conference-call-on-monday-august-8 2026-03-23T10:45:16-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/291/decisiondx-melanoma-ordered-more-than-100000-times-for-patients-diagnosed-with-cutaneous-melanoma 2026-03-23T10:45:16-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/292/presentation-at-2022-aad-innovation-academy-to-showcase-the-risk-stratification-of-decisiondx-melanoma-and-its-role-in-the-management-of-patients-with-cutaneous-melanoma 2026-03-23T10:45:16-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/293/castle-biosciences-honored-with-a-2022-arizona-top-workplace-award 2026-03-23T10:45:16-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/294/patients-with-uveal-melanoma-tested-with-decisiondx-um-report-gaining-value-from-test-results-in-study-conducted-in-collaboration-with-the-melanoma-research-foundations-cure-om-initiative 2026-03-23T10:45:17-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/295/castle-adds-to-evidence-supporting-its-skin-cancer-test-portfolio-through-multiple-data-presentations-at-the-sdpa-annual-summer-dermatology-conference-2022 2026-03-23T10:45:17-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/296/castle-biosciences-announces-support-for-ohsus-war-on-melanoma 2026-03-23T10:45:17-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/297/collaborative-study-with-melanoma-research-foundation-confirms-patients-diagnosed-with-melanoma-desire-testing-with-decisiondx-melanoma 2026-03-23T10:45:17-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/298/castle-biosciences-to-present-at-the-jmp-securities-life-sciences-conference 2026-03-23T10:45:17-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/299/castle-biosciences-decisiondx-melanoma-test-receives-2022-medtech-breakthrough-award 2026-03-23T10:45:17-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/300/data-demonstrating-decisiondx-melanomas-ability-to-risk-stratify-patients-according-to-melanoma-specific-survival-to-be-shared-during-the-2022-asco-annual-meeting 2026-03-23T10:45:18-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/301/tissuecypher-outperforms-pathologist-diagnoses-when-predicting-progression-in-patients-diagnosed-with-barretts-esophagus-with-low-grade-dysplasia 2026-03-23T10:45:18-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/302/grant-from-research-to-prevent-blindness-and-castle-biosciences-supports-medical-student-research-in-ocular-cancer 2026-03-23T10:45:18-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/303/data-from-second-independent-multi-center-study-of-patients-with-high-risk-cutaneous-squamous-cell-carcinoma-confirms-independent-risk-stratification-performance-of-decisiondx-scc 2026-03-23T10:45:18-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/304/castle-biosciences-collaborates-with-the-sun-bus-to-provide-free-skin-cancer-screenings 2026-03-23T10:45:18-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/305/castle-biosciences-reports-first-quarter-2022-results 2026-03-23T10:45:18-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/306/camille-schrier-miss-america-2020-and-castle-biosciences-partner-to-expand-awareness-of-genetic-testing-in-depression-and-anxiety 2026-03-23T10:45:18-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/307/castle-biosciences-recognizes-skin-cancer-awareness-month-through-its-support-of-patient-focused-initiatives 2026-03-23T10:45:18-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/308/castle-biosciences-announces-expanded-u-s-federal-supply-schedule-contract-covering-its-entire-dermatologic-cancer-portfolio-of-tests 2026-03-23T10:45:18-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/309/data-from-independent-pooled-analysis-show-significantly-improved-risk-predictions-over-clinical-variables-for-tissuecypher-barretts-esophagus-test-and-ability-to-identify-patients-at-high-risk-of-progressing-to-esophageal-cancer 2026-03-23T10:45:19-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/310/castle-biosciences-completes-acquisition-of-altheadx 2026-03-23T10:45:19-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/311/castle-biosciences-to-release-first-quarter-2022-financial-results-and-host-conference-call-on-monday-may-9 2026-03-23T10:45:19-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/312/expanded-seer-registries-dataset-shows-improved-survival-for-decisiondx-melanoma-tested-patients-compared-to-untested-patients 2026-03-23T10:45:19-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/313/castle-biosciences-to-present-data-at-the-18th-european-association-of-dermato-oncology-eado-congress 2026-03-23T10:45:19-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/314/castle-biosciences-presents-data-on-its-inflammatory-skin-disease-pipeline-test-at-the-4th-annual-revolutionizing-atopic-dermatitis-rad-conference 2026-03-23T10:45:19-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/315/castle-biosciences-to-present-at-the-21st-annual-needham-virtual-healthcare-conference 2026-03-23T10:45:19-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/316/castle-biosciences-to-acquire-altheadx 2026-03-23T10:45:19-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/317/castle-biosciences-receives-advanced-diagnostic-laboratory-test-adlt-status-for-tissuecypher-barretts-esophagus-test-from-the-centers-for-medicare-medicaid-services-cms 2026-03-23T10:45:19-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/318/data-to-be-presented-at-the-2022-american-academy-of-dermatology-aad-annual-meeting-demonstrate-ability-of-decisiondx-melanoma-and-decisiondx-scc-to-inform-clinical-decision-making 2026-03-23T10:45:19-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/319/independent-data-presented-at-society-for-surgical-oncology-conference-demonstrated-decisiondx-melanoma-outperforms-t-stage-at-identifying-patients-with-low-risk-of-sentinel-lymph-node-positivity 2026-03-23T10:45:19-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/320/castle-biosciences-to-present-at-upcoming-investor-conferences 2026-03-23T10:45:20-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/321/castle-biosciences-reports-fourth-quarter-and-full-year-2021-results 2026-03-23T10:45:20-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/322/castle-biosciences-to-release-fourth-quarter-and-full-year-2021-financial-results-and-host-conference-call-on-monday-feb-28-2022 2026-03-23T10:45:20-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/323/castle-biosciences-to-present-at-the-11th-annual-svb-leerink-global-healthcare-conference 2026-03-23T10:45:20-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/324/castle-biosciences-collaborates-with-the-national-cancer-institute-to-link-decisiondx-melanoma-testing-data-with-seer-registries-cutaneous-melanoma-cases 2026-03-23T10:45:20-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/325/castle-biosciences-named-a-winner-of-the-2022-top-workplaces-usa-award 2026-03-23T10:45:21-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/326/castle-biosciences-to-present-data-at-maui-derm-for-dermatologists-2022 2026-03-23T10:45:21-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/327/recently-published-data-confirm-decisiondx-scc-as-a-significant-and-independent-risk-stratification-tool-in-patients-with-squamous-cell-carcinoma-and-one-or-more-risk-factors 2026-03-23T10:45:21-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/328/data-published-in-ocular-oncology-and-pathology-demonstrates-highly-accurate-performance-of-decisiondx-umseq-for-patients-with-uveal-melanoma 2026-03-23T10:45:21-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/329/castle-biosciences-announces-preliminary-fourth-quarter-and-full-year-2021-results 2026-03-23T10:45:21-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/330/castle-biosciences-to-present-at-the-24th-annual-needham-growth-conference 2026-03-23T10:45:21-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/331/castle-biosciences-completes-acquisition-of-cernostics 2026-03-23T10:45:21-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/332/castle-biosciences-presents-data-reinforcing-the-clinical-utility-of-its-decisiondx-dermatologic-portfolio 2026-03-23T10:45:21-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/333/data-demonstrating-decisiondx-melanoma-was-a-significant-independent-predictor-of-metastatic-recurrence-in-stage-i-iii-cutaneous-melanoma-published-in-future-oncology 2026-03-23T10:45:21-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/334/castle-biosciences-named-in-inc-s-first-annual-best-led-companies 2026-03-23T10:45:21-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/335/castle-biosciences-named-a-2021-houston-chronicle-top-workplace 2026-03-23T10:45:21-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/336/castle-biosciences-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-and-digital-health-services-forum 2026-03-23T10:45:21-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/337/castle-biosciences-announces-third-quarter-2021-results 2026-03-23T10:45:22-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/338/castle-biosciences-releases-inaugural-environmental-social-and-governance-esg-report 2026-03-23T10:45:22-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/339/castle-biosciences-publishes-decisiondx-melanoma-study-on-the-validation-of-the-i31-gep-slnb-artificial-intelligence-algorithm 2026-03-23T10:45:22-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/340/castle-biosciences-full-decisiondx-portfolio-of-dermatologic-tests-to-be-interfaced-with-ema-electronic-health-records-system 2026-03-23T10:45:22-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/341/decisiondx-melanoma-integrated-test-result-now-includes-i31-gep-for-risk-of-recurrence 2026-03-23T10:45:22-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/342/new-data-demonstrating-accuracy-of-decisiondx-diffdx-melanoma-presented-at-asdp-58th-annual-meeting 2026-03-23T10:45:22-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/343/castle-biosciences-to-release-third-quarter-2021-financial-results-and-host-conference-call-on-monday-nov-8-2021 2026-03-23T10:45:22-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/344/castle-biosciences-presents-data-from-suite-of-dermatologic-cancer-genomic-tests-at-fall-clinical-dermatology-conference-2021 2026-03-23T10:45:22-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/345/castle-biosciences-to-acquire-cernostics 2026-03-23T10:45:22-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/346/castle-biosciences-president-and-ceo-derek-maetzold-will-deliver-keynote-presentation-during-arizona-bioscience-week 2026-03-23T10:45:22-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/347/castle-biosciences-announces-new-york-approval-of-decisiondx-diffdx-melanoma 2026-03-23T10:45:23-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/348/castle-biosciences-recognized-as-a-top-100-healthcare-technology-company-of-2021 2026-03-23T10:45:23-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/349/castle-biosciences-to-present-at-upcoming-investor-conferences 2026-03-23T10:45:23-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/350/castle-biosciences-awarded-u-s-federal-supply-schedule-contract-for-decisiondx-melanoma 2026-03-23T10:45:23-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/351/castle-biosciences-presents-new-data-on-decisiondx-melanoma-and-decisiondx-scc-at-the-2021-american-academy-of-dermatology-aad-summer-meeting 2026-03-23T10:45:23-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/352/castle-biosciences-announces-second-quarter-2021-results 2026-03-23T10:45:23-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/353/castle-biosciences-to-present-data-at-the-2021-american-academy-of-dermatology-aad-summer-meeting 2026-03-23T10:45:23-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/354/castle-biosciences-presents-data-on-decisiondx-melanoma-and-decisiondx-scc-at-the-derm2021-nppa-cme-conference 2026-03-23T10:45:23-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/355/castle-biosciences-collaborates-with-the-melanoma-research-foundation 2026-03-23T10:45:24-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/356/castle-biosciences-to-participate-at-the-canaccord-genuity-41st-annual-growth-conference 2026-03-23T10:45:24-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/357/castle-biosciences-to-release-second-quarter-2021-financial-results-and-host-conference-call-on-monday-aug-9-2021 2026-03-23T10:45:24-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/358/castle-biosciences-presents-new-data-demonstrating-decisiondx-scc-complements-current-risk-assessment-methods-in-patients-with-cutaneous-squamous-cell-carcinoma-of-the-head-and-neck 2026-03-23T10:45:24-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/359/castle-biosciences-presents-data-on-decisiondx-melanoma-and-decisiondx-scc-at-sdpa-annual-summer-dermatology-conference-2021 2026-03-23T10:45:24-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/360/castle-biosciences-expands-its-board-of-directors-with-new-appointments 2026-03-23T10:45:25-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/361/castle-biosciences-is-listed-in-the-houston-chronicles-chron-100-as-one-of-the-100-most-successful-publicly-traded-companies-in-houston 2026-03-23T10:45:25-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/362/castle-biosciences-announces-receipt-of-new-york-laboratory-permit 2026-03-23T10:45:25-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/363/castle-biosciences-to-participate-at-the-baird-2021-healthcare-esg-symposium 2026-03-23T10:45:25-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/364/castle-biosciences-to-host-ribbon-cutting-ceremony-at-new-corporate-headquarters 2026-03-23T10:45:25-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/365/castle-biosciences-supports-the-american-skin-association-with-research-grant 2026-03-23T10:45:25-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/366/expert-panel-provides-framework-for-incorporating-decisiondx-scc-results-into-clinical-decision-making-for-cutaneous-squamous-cell-carcinoma-patients-with-one-or-more-risk-factors 2026-03-23T10:45:25-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/367/castle-biosciences-to-participate-in-the-oppenheimer-medtech-tools-diagnostics-summit 2026-03-23T10:45:25-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/368/tiffany-olson-seasoned-diagnostics-executive-joins-castle-biosciences-board-of-directors 2026-03-23T10:45:25-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/369/castle-biosciences-announces-first-quarter-2021-results 2026-03-23T10:45:25-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/370/castle-biosciences-announces-pipeline-initiative-to-develop-genomic-test-targeting-systemic-therapy-response-in-patients-with-psoriasis-atopic-dermatitis-and-related-conditions 2026-03-23T10:45:26-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/371/castle-biosciences-recognized-for-skin-cancer-diagnostics-innovation-in-2021-medtech-breakthrough-awards-program 2026-03-23T10:45:26-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/372/new-data-demonstrate-that-99-of-surveyed-patients-diagnosed-with-uveal-melanoma-gain-value-from-decisiondx-um-test 2026-03-23T10:45:26-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/373/castle-biosciences-collaborates-with-the-colorado-melanoma-foundation-and-epiphany-dermatology-to-provide-free-skin-cancer-screenings-across-the-southwest-u-s 2026-03-23T10:45:26-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/374/castle-biosciences-supports-american-academy-of-dermatologys-skin-cancer-take-a-hike-steps-challenge-for-skin-cancer-awareness-month 2026-03-23T10:45:26-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/375/castle-biosciences-signs-definitive-agreement-to-acquire-myriad-mypath-laboratory 2026-03-23T10:45:26-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/376/castle-biosciences-to-release-first-quarter-2021-financial-results-provide-pipeline-update-and-host-conference-call-on-monday-may-10-2021 2026-03-23T10:45:26-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/377/castle-biosciences-presents-data-demonstrating-decisiondx-melanoma-as-significant-independent-predictor-of-recurrence-in-stage-i-cutaneous-melanoma-population 2026-03-23T10:45:26-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/378/castle-biosciences-presents-data-at-the-dermatology-nurses-association-2021-annual-convention 2026-03-23T10:45:26-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/379/castle-biosciences-presents-data-at-the-10th-world-congress-of-melanoma-and-17th-european-association-of-dermato-oncology-congress 2026-03-23T10:45:26-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/380/late-breaking-new-independent-validation-study-of-1674-patients-demonstrates-castle-biosciences-i31-gep-artificial-intelligence-algorithm-improves-precision-of-sentinel-lymph-node-positivity-prediction-in-cutaneous-melanoma 2026-03-23T10:45:27-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/381/largest-independent-prospective-study-demonstrates-utility-of-decisiondx-melanoma-for-prediction-of-outcomes-in-patients-with-cutaneous-melanoma-referred-for-sentinel-node-biopsy 2026-03-23T10:45:27-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/382/castle-biosciences-announces-prospective-multi-center-publication-demonstrating-decisiondx-melanoma-as-significant-independent-predictor-of-patient-outcomes-in-cutaneous-melanoma 2026-03-23T10:45:27-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/383/castle-biosciences-collaborates-with-the-melanoma-research-foundation-for-ask-the-expert-live-webinar-series-with-melanoma-experts 2026-03-23T10:45:27-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/384/castle-biosciences-to-present-at-the-20th-annual-needham-virtual-healthcare-conference 2026-03-23T10:45:27-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/385/castle-biosciences-announces-publication-demonstrating-dermatologists-are-increasingly-integrating-decisiondx-melanoma-into-melanoma-clinical-management-decisions 2026-03-23T10:45:27-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/386/castle-biosciences-announces-fourth-quarter-and-full-year-2020-results 2026-03-23T10:45:27-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/387/castle-biosciences-launches-decisiondx-melanoma-integrated-test-result-utilizing-artificial-intelligence-to-predict-individualized-risk 2026-03-23T10:45:27-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/388/castle-biosciences-to-release-fourth-quarter-and-full-year-2020-financial-results-and-host-conference-call-on-monday-march-8-2021 2026-03-23T10:45:27-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/389/castle-biosciences-to-present-at-upcoming-investor-conferences 2026-03-23T10:45:28-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/390/castle-biosciences-presents-new-data-on-the-validity-and-accuracy-of-decisiondx-melanoma-in-patients-with-t1-cutaneous-melanoma-tumors-at-the-19th-annual-south-beach-symposium 2026-03-23T10:45:28-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/391/castle-biosciences-to-present-data-on-decisiondx-melanoma-decisiondx-diffdx-melanoma-at-18th-annual-winter-clinical-dermatology-conference 2026-03-23T10:45:28-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/392/castle-biosciences-announces-preliminary-fourth-quarter-and-full-year-2020-results 2026-03-23T10:45:28-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/393/castle-biosciences-to-present-at-the-23rd-annual-needham-virtual-growth-conference 2026-03-23T10:45:28-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/394/castle-biosciences-announces-early-repayment-of-debt 2026-03-23T10:45:28-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/395/castle-biosciences-announces-closing-of-public-offering-of-common-stock-and-full-exercise-of-underwriters-option-to-purchase-additional-shares 2026-03-23T10:45:28-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/396/castle-biosciences-announces-pricing-of-232-million-public-offering-of-common-stock 2026-03-23T10:45:28-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/397/castle-biosciences-announces-commencement-of-proposed-public-offering-of-common-stock 2026-03-23T10:45:28-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/398/castle-biosciences-announces-publication-of-peer-reviewed-publication-demonstrating-the-clinical-impact-of-decisiondx-melanoma 2026-03-23T10:45:28-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/399/castle-biosciences-to-participate-in-piper-sandler-32nd-annual-virtual-healthcare-conference 2026-03-23T10:45:28-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/400/castle-biosciences-announces-publication-of-clinical-validation-and-utility-data-for-decisiondx-diffdx-melanoma-for-suspicious-pigmented-lesions 2026-03-23T10:45:28-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/401/castle-biosciences-presents-data-on-decisiondx-melanoma-and-decisiondx-diffdx-melanoma-tests-at-american-society-of-dermatopathology-asdp-57th-virtual-annual-meeting 2026-03-23T10:45:29-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/402/castle-biosciences-announces-third-quarter-2020-results 2026-03-23T10:45:29-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/403/castle-biosciences-to-present-at-the-canaccord-genuity-2020-virtual-medtech-diagnostics-forum 2026-03-23T10:45:29-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/404/castle-biosciences-announces-commercial-launch-of-decisiondx-diffdx-melanoma 2026-03-23T10:45:30-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/405/castle-biosciences-to-present-data-at-the-american-society-of-dermatopathology-asdp-57th-virtual-annual-meeting 2026-03-23T10:45:30-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/406/castle-biosciences-to-release-third-quarter-2020-financial-results-and-host-conference-call-on-monday-november-9-2020 2026-03-23T10:45:30-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/407/castle-biosciences-to-hold-webcast-for-investors-highlighting-commercial-launch-of-confirmdx-melanoma 2026-03-23T10:45:30-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/408/castle-biosciences-presents-data-on-decisiondx-melanoma-at-the-virtual-european-association-of-dermato-oncology-eado-congress 2026-03-23T10:45:30-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/409/castle-biosciences-presents-data-at-the-2020-american-society-for-dermatologic-surgery-asds-virtual-annual-meeting 2026-03-23T10:45:30-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/410/castle-biosciences-announces-expanded-medicare-coverage-for-decisiondx-melanoma-in-cutaneous-melanoma 2026-03-23T10:45:30-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/411/castle-biosciences-to-present-data-at-the-2020-american-society-for-dermatologic-surgery-asds-virtual-annual-meeting 2026-03-23T10:45:30-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/412/castle-biosciences-to-present-at-the-baird-2020-global-healthcare-conference 2026-03-23T10:45:31-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/413/castle-biosciences-announces-commercial-launch-of-decisiondx-scc 2026-03-23T10:45:31-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/414/castle-biosciences-announces-leadership-promotions-and-new-medical-director 2026-03-23T10:45:31-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/415/castle-biosciences-to-hold-webcast-highlighting-commercial-launch-of-decisiondx-scc 2026-03-23T10:45:31-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/416/castle-biosciences-announces-second-quarter-2020-results 2026-03-23T10:45:31-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/417/castle-biosciences-to-present-at-the-canaccord-genuity-40th-annual-growth-conference 2026-03-23T10:45:31-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/418/castle-biosciences-to-release-second-quarter-2020-financial-results-and-host-conference-call-on-monday-august-10-2020 2026-03-23T10:45:31-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/419/castle-biosciences-announces-publication-of-clinical-utility-long-term-outcomes-data-and-meta-analysis-for-decisiondx-um-for-patients-with-uveal-melanoma 2026-03-23T10:45:31-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/420/second-systematic-review-and-meta-analysis-published-demonstrating-decisiondx-melanoma-as-independent-predictor-of-recurrence-distant-metastasis-and-overall-survival-in-cutaneous-melanoma 2026-03-23T10:45:31-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/421/castle-biosciences-announces-full-exercise-of-underwriters-option-to-purchase-additional-shares-of-common-stock 2026-03-23T10:45:31-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/422/castle-biosciences-announces-pricing-of-74-0-million-public-offering-of-common-stock 2026-03-23T10:45:31-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/423/castle-biosciences-announces-proposed-underwritten-public-offering-of-common-stock 2026-03-23T10:45:31-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/424/castle-biosciences-announces-change-of-location-of-annual-meeting-of-stockholders-to-be-held-june-4-2020 2026-03-23T10:45:32-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/425/new-data-demonstrates-significant-and-risk-appropriate-clinical-impact-of-decisiondx-scc-test-results-on-patient-management-decisions 2026-03-23T10:45:32-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/426/castle-biosciences-announces-first-quarter-2020-results 2026-03-23T10:45:32-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/427/castle-biosciences-announces-publication-of-a-study-evaluating-incorporation-of-decisiondx-scc-into-management-of-high-risk-cutaneous-squamous-cell-carcinoma 2026-03-23T10:45:32-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/428/castle-biosciences-announces-publication-of-validation-study-for-decisiondx-scc-showing-this-test-is-an-independent-predictor-of-metastatic-risk-in-squamous-cell-carcinoma 2026-03-23T10:45:32-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/429/castle-biosciences-to-release-first-quarter-2020-financial-results-and-host-conference-call-on-monday-may-11-2020 2026-03-23T10:45:32-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/430/castle-biosciences-to-present-at-the-19th-annual-needham-virtual-healthcare-conference 2026-03-23T10:45:32-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/431/castle-biosciences-appoints-miles-harrison-to-board-of-directors 2026-03-23T10:45:32-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/432/castle-biosciences-announces-publication-of-a-systematic-review-and-meta-analysis-demonstrating-decisiondx-melanoma-test-as-independent-significant-predictor-of-recurrence-and-metastatic-risk 2026-03-23T10:45:33-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/433/castle-biosciences-posts-results-of-collaborative-ocular-oncology-group-survey-on-the-management-of-ocular-oncology-patients-during-the-covid-19-pandemic 2026-03-23T10:45:33-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/434/castle-biosciences-announces-publication-of-fourth-study-demonstrating-significant-impact-of-decisiondx-um-on-treatment-plan-recommendations-for-patients-with-uveal-melanoma 2026-03-23T10:45:33-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/435/castle-biosciences-announces-fourth-quarter-and-full-year-2019-results 2026-03-23T10:45:33-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/436/castle-biosciences-announces-issuance-of-first-u-s-patent-covering-decisiondx-melanoma 2026-03-23T10:45:33-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/437/castle-biosciences-to-release-fourth-quarter-and-full-year-2019-financial-results-and-host-conference-call-on-tuesday-march-10-2020 2026-03-23T10:45:33-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/438/castle-biosciences-to-present-at-the-9th-annual-svb-leerink-global-healthcare-conference 2026-03-23T10:45:33-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/439/castle-biosciences-announces-study-establishing-the-value-of-integrating-decisiondx-scc-test-into-management-of-high-risk-cutaneous-squamous-cell-carcinoma 2026-03-23T10:45:33-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/440/castle-biosciences-announces-preliminary-fourth-quarter-and-full-year-2019-performance-results-delivering-29-decisiondx-melanoma-test-report-volume-growth-in-2019 2026-03-23T10:45:34-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/441/castle-biosciences-announces-level-of-evidence-review-on-decisiondx-melanoma-published-in-latest-issue-of-american-journal-of-clinical-dermatology 2026-03-23T10:45:34-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/442/castle-biosciences-added-to-nasdaq-biotechnology-index 2026-03-23T10:45:34-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/443/castle-biosciences-announces-time-change-for-presentation-at-the-evercore-isi-second-annual-healthconx 2026-03-23T10:45:34-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/444/castle-biosciences-presents-expanded-data-supporting-use-of-decisiondx-melanoma-test-to-inform-sentinel-lymph-node-biopsy-recommendations 2026-03-23T10:45:34-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/445/castle-biosciences-to-present-at-upcoming-investor-conferences 2026-03-23T10:45:34-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/446/castle-biosciences-reports-third-quarter-2019-results 2026-03-23T10:45:34-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/447/study-results-confirm-newly-developed-nomogram-using-castle-biosciences-decisiondx-melanoma-test-improves-assessment-of-melanoma-patient-risk 2026-03-23T10:45:34-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/448/castle-biosciences-presents-clinical-validation-study-for-its-cutaneous-squamous-cell-carcinoma-prognostic-test-at-the-american-society-for-dermatologic-surgery-asds-2019-annual-meeting 2026-03-23T10:45:34-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/450/castle-biosciences-presents-second-study-confirming-ability-of-decisiondx-melanoma-to-inform-sentinel-lymph-node-biopsy-decisions-at-the-8th-international-congress-on-cancer-metastasis 2026-03-23T10:45:34-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/449/castle-biosciences-to-release-third-quarter-2019-financial-results-and-host-conference-call-on-monday-november-11-2019 2026-03-23T10:45:34-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/451/castle-biosciences-presents-data-at-the-asdp-56th-annual-meeting-supporting-decisiondx-melanoma-tests-ability-to-identify-t1-melanoma-patients-at-low-risk-for-a-positive-sentinel-lymph-node 2026-03-23T10:45:34-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/452/castle-biosciences-announces-presentation-of-prospective-multicenter-study-demonstrating-significant-impact-of-decisiondx-um-on-treatment-plan-recommendations-for-patients-with-uveal-melanoma 2026-03-23T10:45:35-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/453/newly-published-systematic-review-confirms-strength-of-evidence-and-outlines-appropriate-use-criteria-for-integration-of-decisiondx-melanoma-in-management-of-patients-with-cutaneous-melanoma 2026-03-23T10:45:35-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/454/castle-biosciences-added-to-membership-of-us-small-cap-russell-2000-index 2026-03-23T10:45:35-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/455/castle-biosciences-announces-time-change-for-presentation-at-the-baird-2019-global-healthcare-conference 2026-03-23T10:45:35-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/456/castle-biosciences-reports-second-quarter-2019-results 2026-03-23T10:45:35-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/457/castle-biosciences-to-present-at-the-baird-2019-global-healthcare-conference 2026-03-23T10:45:35-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/458/castle-biosciences-to-release-second-quarter-2019-financial-results-and-host-conference-call-on-tuesday-september-3-2019 2026-03-23T10:45:35-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/459/castle-biosciences-announces-closing-of-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares 2026-03-23T10:45:35-04:00 https://ir.castlebiosciences.com/news-events/press-releases/detail/460/castle-biosciences-announces-pricing-of-initial-public-offering 2026-03-23T10:45:35-04:00 https://ir.castlebiosciences.com/news-events/ir-events/detail/20260603-jefferies-global-healthcare-conference 2026-05-13T09:33:20-04:00 https://ir.castlebiosciences.com/news-events/ir-events/detail/20260506-castle-biosciences-q1-2026-earnings-call 2026-05-13T09:30:21-04:00 https://ir.castlebiosciences.com/news-events/ir-events/detail/20260323-castle-biosciences-decisiondx-melanoma-webcast 2026-05-21T12:33:32-04:00 https://ir.castlebiosciences.com/news-events/ir-events/detail/20260226-castle-biosciences-q4-2025-earnings-call 2026-04-16T18:18:56-04:00 https://ir.castlebiosciences.com/sec-filings/all-sec-filings/content/0001628280-26-037724/wk-form4_1779480745.html 2026-05-22T16:12:56-04:00 https://ir.castlebiosciences.com/sec-filings/all-sec-filings/content/0001104659-26-062538/primary_doc.html 2026-05-15T16:19:25-04:00 https://ir.castlebiosciences.com/sec-filings/all-sec-filings/content/0001493215-26-000096/primary_doc.html 2026-05-15T08:11:28-04:00 https://ir.castlebiosciences.com/sec-filings/all-sec-filings/content/0001628280-26-033446/wk-form4_1778529974.html 2026-05-11T16:14:22-04:00 https://ir.castlebiosciences.com/sec-filings/all-sec-filings/content/0001958244-26-000262/primary_doc.html 2026-05-07T17:10:50-04:00 https://ir.castlebiosciences.com/sec-filings/all-sec-filings/content/0001628280-26-031263/cstl-20260331.htm 2026-05-06T16:13:23-04:00 https://ir.castlebiosciences.com/sec-filings/all-sec-filings/content/0001628280-26-031255/cstl-20260506.htm 2026-05-06T16:11:19-04:00 https://ir.castlebiosciences.com/sec-filings/all-sec-filings/content/0001628280-26-026851/wk-form4_1776975402.html 2026-04-23T16:23:12-04:00 https://ir.castlebiosciences.com/sec-filings/all-sec-filings/content/0001628280-26-024264/wk-form4_1775680461.html 2026-04-08T16:34:59-04:00 https://ir.castlebiosciences.com/sec-filings/all-sec-filings/content/0001628280-26-024168/0001628280-26-024168.pdf 2026-04-08T10:16:21-04:00 https://ir.castlebiosciences.com/sec-filings/all-sec-filings/content/0001628280-26-024167/a2026proxynoticeofinternet.htm 2026-04-08T10:14:35-04:00 https://ir.castlebiosciences.com/sec-filings/all-sec-filings/content/0001628280-26-024166/cstl-20260407.htm 2026-04-08T10:14:30-04:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34737/corporate-presentation 2022-01-10T00:00:00-05:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34738/corporate-presentation 2022-02-28T00:00:00-05:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34739/corporate-presentation 2022-05-09T00:00:00-04:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34740/corporate-presentation 2022-08-08T00:00:00-04:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34741/investor-day-presentation 2022-09-20T00:00:00-04:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34742/corporate-presentation 2022-11-02T00:00:00-04:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34743/corporate-presentation 2023-01-09T00:00:00-05:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34744/corporate-presentation 2023-02-28T00:00:00-05:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34745/corporate-presentation 2023-03-09T00:00:00-05:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34746/corporate-presentation 2023-05-03T00:00:00-04:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34747/corporate-presentation 2023-05-08T00:00:00-04:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34748/corporate-presentation 2023-08-02T00:00:00-04:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34749/corporate-presentation 2023-11-02T00:00:00-04:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34750/castle-preliminary-fourth-quarter-and-full-year-2023-results-slide-presentation 2024-01-08T00:00:00-05:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34751/corporate-presentation 2024-02-28T00:00:00-05:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34752/corporate-presentation 2024-05-02T00:00:00-04:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34753/corporate-presentation 2024-08-05T00:00:00-04:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34754/corporate-presentation 2024-11-04T00:00:00-05:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34755/castle-preliminary-fourth-quarter-and-full-year-2024-results-slide-presentation 2025-01-12T00:00:00-05:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34756/corporate-presentation 2025-02-27T00:00:00-05:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34757/corporate-presentation 2025-05-05T00:00:00-04:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34758/corporate-presentation 2025-08-04T00:00:00-04:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34759/corporate-presentation 2025-11-03T00:00:00-05:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34760/castle-preliminary-fourth-quarter-and-full-year-2025-results-slide-presentation 2026-01-11T00:00:00-05:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34761/corporate-presentation 2026-02-26T00:00:00-05:00 https://ir.castlebiosciences.com/news-events/presentations/detail/34926/corporate-presentation 2026-05-06T00:00:00-04:00 https://ir.castlebiosciences.com/disclaimer https://ir.castlebiosciences.com/sitemap https://ir.castlebiosciences.com/accessibility-statement